Galectin Therapeutics
GALT
GALT
59 hedge funds and large institutions have $18.2M invested in Galectin Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
11% less funds holding
Funds holding: 66 → 59 (-7)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
59
Holding in Top 10
–
Calls
$154K
Puts
$16K
Top Buyers
| 1 | +$671K | |
| 2 | +$513K | |
| 3 | +$126K | |
| 4 |
Squarepoint
New York
|
+$115K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$90.9K |
Top Sellers
| 1 | -$444K | |
| 2 | -$184K | |
| 3 | -$90K | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
-$83.7K |
| 5 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
-$59.9K |